Dabigatran Associated Leukocytoclastic Vasculitis

Common side effects of dabigatran are bleeding, bruising, nausea, diarrhea, and abdomen discomfort. Skin reactions were not often noted (<0.1%). We report a case of 70-year-old male who developed dabigatran related skin reaction resistant to usual therapy. Skin biopsy revealed leukocytoclastic va...

Descripción completa

Detalles Bibliográficos
Autores principales: Potolidis, Evangelos, Mandros, Charalampos, Kotsa, Kalliopi, Mitsiou, Evdoxia, Potolidis, Dimitris, Fanourgiakis, Panagiotis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710900/
https://www.ncbi.nlm.nih.gov/pubmed/26843867
http://dx.doi.org/10.1155/2015/616109
_version_ 1782409877498363904
author Potolidis, Evangelos
Mandros, Charalampos
Kotsa, Kalliopi
Mitsiou, Evdoxia
Potolidis, Dimitris
Fanourgiakis, Panagiotis
author_facet Potolidis, Evangelos
Mandros, Charalampos
Kotsa, Kalliopi
Mitsiou, Evdoxia
Potolidis, Dimitris
Fanourgiakis, Panagiotis
author_sort Potolidis, Evangelos
collection PubMed
description Common side effects of dabigatran are bleeding, bruising, nausea, diarrhea, and abdomen discomfort. Skin reactions were not often noted (<0.1%). We report a case of 70-year-old male who developed dabigatran related skin reaction resistant to usual therapy. Skin biopsy revealed leukocytoclastic vasculitis.
format Online
Article
Text
id pubmed-4710900
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-47109002016-02-03 Dabigatran Associated Leukocytoclastic Vasculitis Potolidis, Evangelos Mandros, Charalampos Kotsa, Kalliopi Mitsiou, Evdoxia Potolidis, Dimitris Fanourgiakis, Panagiotis Case Rep Med Case Report Common side effects of dabigatran are bleeding, bruising, nausea, diarrhea, and abdomen discomfort. Skin reactions were not often noted (<0.1%). We report a case of 70-year-old male who developed dabigatran related skin reaction resistant to usual therapy. Skin biopsy revealed leukocytoclastic vasculitis. Hindawi Publishing Corporation 2015 2015-12-30 /pmc/articles/PMC4710900/ /pubmed/26843867 http://dx.doi.org/10.1155/2015/616109 Text en Copyright © 2015 Evangelos Potolidis et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Potolidis, Evangelos
Mandros, Charalampos
Kotsa, Kalliopi
Mitsiou, Evdoxia
Potolidis, Dimitris
Fanourgiakis, Panagiotis
Dabigatran Associated Leukocytoclastic Vasculitis
title Dabigatran Associated Leukocytoclastic Vasculitis
title_full Dabigatran Associated Leukocytoclastic Vasculitis
title_fullStr Dabigatran Associated Leukocytoclastic Vasculitis
title_full_unstemmed Dabigatran Associated Leukocytoclastic Vasculitis
title_short Dabigatran Associated Leukocytoclastic Vasculitis
title_sort dabigatran associated leukocytoclastic vasculitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710900/
https://www.ncbi.nlm.nih.gov/pubmed/26843867
http://dx.doi.org/10.1155/2015/616109
work_keys_str_mv AT potolidisevangelos dabigatranassociatedleukocytoclasticvasculitis
AT mandroscharalampos dabigatranassociatedleukocytoclasticvasculitis
AT kotsakalliopi dabigatranassociatedleukocytoclasticvasculitis
AT mitsiouevdoxia dabigatranassociatedleukocytoclasticvasculitis
AT potolidisdimitris dabigatranassociatedleukocytoclasticvasculitis
AT fanourgiakispanagiotis dabigatranassociatedleukocytoclasticvasculitis

Ejemplares similares